Pear Therapeutics (Somryst) Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Pear Therapeutics (Somryst) General Information

Description

Operator of a digital therapeutic platform intended for adults with chronic insomnia. The company delivers effective, first-line treatment and offers healthcare programs through its online application, thereby seeking to reframe sleep as a tool for managing chronic health conditions.

Contact Information

Website
www.somryst.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 200 State Street
  • Boston, MA 02109
  • United States
Primary Industry
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Corporate Office
  • 200 State Street
  • Boston, MA 02109
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Therapeutics (Somryst) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pear Therapeutics (Somryst)‘s full profile, request access.

Request a free trial

Pear Therapeutics (Somryst) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pear Therapeutics (Somryst)‘s full profile, request access.

Request a free trial

Pear Therapeutics (Somryst) FAQs

  • When was Pear Therapeutics (Somryst) founded?

    Pear Therapeutics (Somryst) was founded in 2020.

  • Where is Pear Therapeutics (Somryst) headquartered?

    Pear Therapeutics (Somryst) is headquartered in Boston, MA.

  • What industry is Pear Therapeutics (Somryst) in?

    Pear Therapeutics (Somryst)’s primary industry is Other Healthcare Technology Systems.

  • Is Pear Therapeutics (Somryst) a private or public company?

    Pear Therapeutics (Somryst) is a Private company.

  • What is the current valuation of Pear Therapeutics (Somryst)?

    The current valuation of Pear Therapeutics (Somryst) is .

  • What is Pear Therapeutics (Somryst)’s current revenue?

    The current revenue for Pear Therapeutics (Somryst) is .

  • Who are Pear Therapeutics (Somryst)’s investors?

    Pear Therapeutics has invested in Pear Therapeutics (Somryst).

  • When was Pear Therapeutics (Somryst) acquired?

    Pear Therapeutics (Somryst) was acquired on 24-May-2023.

  • Who acquired Pear Therapeutics (Somryst)?

    Pear Therapeutics (Somryst) was acquired by Nox Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process